RecruitMe Clinical Trial

CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Study of Patients Receiving an Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Sponsor:Investigator initiated study
Enrolling:Male and Female Patients
Maximum Age:40 years old
IRB Number:AAAL0156
U.S. Government ID:NCT01966367
Contact: Brian Volonte: (212) 304-7806 / bv2272@cumc.columbia.edu
Additional Study Information:

The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a non-malignant condition.

Do You Qualify?
Is the patient 40 years of age or younger?YesNo
Is the patient a candidate for stem cell transplant for a non-malignant disease?YesNo
Submit
Cancel
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Brian Volonte
Email: bv2272@cumc.columbia.edu
Phone: (212) 304-7806